Unadjusted and adjusted hazard risks for long-term clinical outcomes between patients with and without proximal LAD lesion
| Endpoints | n | Unadjusted | Adjusted | ||
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| All-cause death at 10 years | 263/1088 | 1.02 (0.80 to 1.30) | 0.863 | 0.95 (0.72 to 1.26) | 0.718 |
| All-cause death at maximum follow-up | 330/1088 | 1.03 (0.83 to 1.28) | 0.786 | 0.98 (0.77 to 1.26) | 0.886 |
| MACCE at 5 years | 323/1088 | 0.95 (0.77 to 1.19) | 0.674 | 0.89 (0.70 to 1.14) | 0.351 |
| All-cause death at 5 years | 124/1088 | 0.96 (0.68 to 1.37) | 0.840 | 0.87 (0.58 to 1.31) | 0.512 |
| Cardiac death at 5 years | 68/1088 | 0.88 (0.55 to 1.42) | 0.601 | 0.89 (0.51 to 1.56) | 0.682 |
| MI at 5 years | 72/1088 | 0.88 (0.55 to 1.39) | 0.583 | 0.83 (0.50 to 1.38) | 0.471 |
| Stroke at 5 years | 32/1088 | 1.22 (0.60 to 2.44) | 0.584 | 1.15 (0.54 to 2.46) | 0.710 |
| Revascularisation at 5 years | 190/1088 | 0.88 (0.66 to 1.17) | 0.386 | 0.82 (0.60 to 1.12) | 0.207 |
The covariables in the adjusted models included age, sex, body mass index, medically treated diabetes, hypertension, dyslipidaemia, current smokers, previous myocardial infarction, previous cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, chronic kidney disease, prescription of statin at discharge, any bifurcations and anatomical SYNTAX score.
‘n’ refers to the number of patients having events/total number of patients in the model.
LAD, left anterior descending artery; MACCE, major adverse cardiac or cerebrovascular events; MI, myocardial infarction; SYNTAX, Synergy between PCI with Taxus and Cardiac Surgery.